• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Director Faulconbridge James A bought $351,036 worth of shares (4,000 units at $87.76), increasing direct ownership by 10% to 46,017 units (SEC Form 4)

    6/12/24 6:02:44 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary
    Get the next $HWKN alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Faulconbridge James A

    (Last) (First) (Middle)
    2381 ROSEGATE

    (Street)
    ROSEVILLE MN 55113

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    HAWKINS INC [ HWKN ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    06/10/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 06/10/2024 P 1,212 A $85.991(1) 43,229 D
    Common Stock 06/10/2024 P 788 A $87.2034(2) 44,017 D
    Common Stock 06/11/2024 P 632 A $88.5807(3) 44,649 D
    Common Stock 06/11/2024 P 1,368 A $89.2661(4) 46,017 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Reflects the weighted average price of 1,212 shares of common stock of Hawkins, Inc. purchased by the reporting person in multiple transactions on June 10, 2024 with purchase prices ranging from $85.50 to $86.37 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
    2. Reflects the weighted average price of 788 shares of common stock of Hawkins, Inc. purchased by the reporting person in multiple transactions on June 10, 2024 with purchase prices ranging from $86.81 to $87.53 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
    3. Reflects the weighted average price of 632 shares of common stock of Hawkins, Inc. purchased by the reporting person in multiple transactions on June 11, 2024 with purchase prices ranging from $88.00 to $88.93 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
    4. Reflects the weighted average price of 1,368 shares of common stock of Hawkins, Inc. purchased by the reporting person in multiple transactions on June 11, 2024 with purchase prices ranging from $89.02 to $89.44 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
    /s/ Joshua L. Colburn, Attorney-in-Fact 06/12/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $HWKN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $HWKN

    DatePrice TargetRatingAnalyst
    7/24/2025Mkt Perform
    Raymond James
    4/14/2025$160.00Neutral → Buy
    BWS Financial
    4/1/2025$125.00Market Outperform
    CJS Securities
    10/16/2024Buy → Neutral
    BWS Financial
    8/7/2023$62.00Neutral → Buy
    BWS Financial
    2/3/2022$44.00 → $52.00Buy
    BWS Financial
    More analyst ratings

    $HWKN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • HAWKINS, INC. TO RELEASE FIRST QUARTER FISCAL 2026 FINANCIAL RESULTS ON JULY 30, 2025

      ROSEVILLE, Minn., July 16, 2025 (GLOBE NEWSWIRE) --  Hawkins, Inc. (NASDAQ:HWKN) announced today that it expects to release its financial results for its fiscal 2026 first quarter ended June 29, 2025 after the market closes on July 30, 2025 at approximately 4:10 p.m. Eastern Time.  About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes, and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 64 facilities in 28 states and creates value for its customers through superb customer se

      7/16/25 8:45:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc. Expands Water Treatment Footprint with Acquisition of PhillTech, LLC

      ROSEVILLE, Minn., July 01, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, has completed the acquisition of PhillTech, LLC. PhillTech, located in Alabama, manufactures and distributes coagulants and corrosion control products for its water treatment customers. "As we continue to execute on our strategy to grow our water treatment business, we believe this tuck-in acquisition will help solidify and grow our production of coagulants and corrosion control products and further improve our position in this market. We have known PhillTech for many years and have built a solid working relationship with their team, having been a s

      7/1/25 9:05:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc. to Participate in CJS Securities 25th Annual New Ideas Summer Conference

      ROSEVILLE, Minn, June 11, 2025 (GLOBE NEWSWIRE) -- – Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, today announced that it will participate in the CJS Securities 25th Annual New Ideas Summer Conference on July 10, 2025. The conference will be held at the Metropolis Country Club in White Plains, NY. The conference will be attended by a group of targeted institutional investors, where each company in attendance will have a presentation slot and will be available for one-on-one meetings. For more information about this conference or to schedule a meeting with Hawkins management, please contact the event coordinators or Hawkins Investor Relations

      6/11/25 9:00:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • VP of Food and Health Sciences Jones Gregory Alan was granted 3,411 shares, increasing direct ownership by 75% to 7,980 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      5/16/25 4:30:47 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • VP-INDUSTRIAL SOLUTIONS GROUP Mangine David J. was granted 3,553 shares, increasing direct ownership by 14% to 29,104 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      5/16/25 4:30:44 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • VP - WATER TREATMENT GROUP Lange Douglas A. was granted 3,553 shares, increasing direct ownership by 14% to 28,792 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      5/16/25 4:30:37 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    SEC Filings

    See more
    • SEC Form DEFA14A filed by Hawkins Inc.

      DEFA14A - HAWKINS INC (0000046250) (Filer)

      6/18/25 9:01:40 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form DEFA14A filed by Hawkins Inc.

      DEFA14A - HAWKINS INC (0000046250) (Filer)

      6/18/25 8:13:57 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form DEF 14A filed by Hawkins Inc.

      DEF 14A - HAWKINS INC (0000046250) (Filer)

      6/18/25 8:13:14 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Raymond James initiated coverage on Hawkins

      Raymond James initiated coverage of Hawkins with a rating of Mkt Perform

      7/24/25 7:27:35 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins upgraded by BWS Financial with a new price target

      BWS Financial upgraded Hawkins from Neutral to Buy and set a new price target of $160.00

      4/14/25 9:28:56 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • CJS Securities initiated coverage on Hawkins with a new price target

      CJS Securities initiated coverage of Hawkins with a rating of Market Outperform and set a new price target of $125.00

      4/1/25 9:13:14 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Faulconbridge James A bought $161,899 worth of shares (1,800 units at $89.94), increasing direct ownership by 4% to 47,817 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      6/14/24 4:09:43 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Director Faulconbridge James A bought $351,036 worth of shares (4,000 units at $87.76), increasing direct ownership by 10% to 46,017 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      6/12/24 6:02:44 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Director Faulconbridge James A bought $288,907 worth of shares (3,300 units at $87.55), increasing direct ownership by 9% to 42,017 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      6/10/24 4:27:25 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Leadership Updates

    Live Leadership Updates

    See more
    • THE TRŪ® SHRIMP COMPANIES APPOINTS HAWKINS AS EXCLUSIVE U.S. DISTRIBUTOR FOR TRŪ® CHITOSAN

      BALATON, Minn., Aug. 16, 2023 /PRNewswire/ -- The trū® Shrimp Companies, Inc. ("trū Shrimp") announced today that trū Shrimp has appointed Hawkins, Inc. ("Hawkins") (NASDAQ:HWKN) as the exclusive distributor of its trū® Chitosan products into the United States' pharmaceutical and medical device industries. trū Chitosan is derived from the exoskeletons of trū Shrimp's production of consumer shrimp. Chitosan is a molecule refined from the shell of shrimp and is used for numerous pharmaceutical and medical applications. trū Shrimp is the only United States producer of chitosan that meets the strict medical specifications of the United States Pharmacopoeia – National Formulary (USP-NF) monograph

      8/16/23 9:00:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc.  Announces Retirement of Director John McKeon

      Minneapolis, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced that John S. McKeon has notified us of his retirement from our Board of Directors and its committees effective as of December 31, 2020.  Mr. McKeon has been a member of the Board since 1984 and has served as Chair of the Board since 2005. “We will miss Jack on the Board and appreciate his many years of dedicated service to Hawkins,” said Patrick H. Hawkins, Chief Executive Officer and President. “Over the 36 years that Jack has served on the Board, we have seen Hawkins grow tremendously in both size and scope.  With his support and guidance, we have built a solid company that is poised for cont

      12/18/20 4:10:00 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Hawkins Inc.

      SC 13G/A - HAWKINS INC (0000046250) (Subject)

      10/31/24 11:54:59 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Hawkins Inc. (Amendment)

      SC 13G/A - HAWKINS INC (0000046250) (Subject)

      2/13/24 5:06:13 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Hawkins Inc. (Amendment)

      SC 13G/A - HAWKINS INC (0000046250) (Subject)

      2/9/24 9:59:13 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Financials

    Live finance-specific insights

    See more
    • HAWKINS, INC. TO RELEASE FIRST QUARTER FISCAL 2026 FINANCIAL RESULTS ON JULY 30, 2025

      ROSEVILLE, Minn., July 16, 2025 (GLOBE NEWSWIRE) --  Hawkins, Inc. (NASDAQ:HWKN) announced today that it expects to release its financial results for its fiscal 2026 first quarter ended June 29, 2025 after the market closes on July 30, 2025 at approximately 4:10 p.m. Eastern Time.  About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes, and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 64 facilities in 28 states and creates value for its customers through superb customer se

      7/16/25 8:45:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc. Expands Water Treatment Footprint with Acquisition of PhillTech, LLC

      ROSEVILLE, Minn., July 01, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, has completed the acquisition of PhillTech, LLC. PhillTech, located in Alabama, manufactures and distributes coagulants and corrosion control products for its water treatment customers. "As we continue to execute on our strategy to grow our water treatment business, we believe this tuck-in acquisition will help solidify and grow our production of coagulants and corrosion control products and further improve our position in this market. We have known PhillTech for many years and have built a solid working relationship with their team, having been a s

      7/1/25 9:05:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc. Reports Fourth Quarter and Fiscal Year 2025 Results

      ROSEVILLE, Minn., May 14, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN) today announced fourth quarter and full-year results for its fiscal year ended March 30, 2025. Fourth Quarter Fiscal Year 2025 Highlights: Record fourth quarter sales of $245.3 million, a 10% increase over the same quarter of the prior year, led by Water Treatment segment sales growth of 21% over the same quarter in the prior year.Record fourth quarter gross profit of $52.2 million, a 15% increase over the same quarter of the prior year, contributing to record fourth quarter operating income of $24.6 million, a 22% increase over the prior year.Record fourth quarter diluted earnings per share (EPS) of $0.78, wh

      5/14/25 4:05:49 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary